Cargando…
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”
Thymic epithelial tumors (TETs) are rare thoracic tumors, often requiring multimodal approaches. Surgery represents the first step of the treatment, possibly followed by adjuvant radiotherapy (RT) and, less frequently, chemotherapy. For unresectable tumors, a combination of chemotherapy and RT is of...
Autores principales: | Angrisani, A., Houben, R., Marcuse, F., Hochstenbag, M., Maessen, J., De Ruysscher, D., Peeters, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960904/ https://www.ncbi.nlm.nih.gov/pubmed/35360004 http://dx.doi.org/10.1016/j.ctro.2022.03.005 |
Ejemplares similares
-
AB004. Radiotherapy for thymic epithelial tumors: what is the optimal dose?—a systematic review
por: Angrisani, Antonio, et al.
Publicado: (2022) -
AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
por: Peeters, Stephanie T. H., et al.
Publicado: (2022) -
Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7
por: Keijzers, Marlies, et al.
Publicado: (2015) -
Radiotherapy for thymic epithelial tumours: a review
por: Süveg, Krisztian, et al.
Publicado: (2021) -
The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022)